PMID: 29769991Nov 3, 2016Paper

Antimicrobial use and antimicrobial resistance trends in Canada: 2014

Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
M EbrahimC Hyson

Abstract

There is a global concern that the emergence of antimicrobial resistance (AMR) threatens our ability to treat infectious diseases. The Canadian Antimicrobial Resistance Surveillance System (CARSS) was created in response to the Government of Canada's commitment to addressing AMR. CARSS integrates information from nine different national surveillance systems for tracking antimicrobial use (AMU) and AMR in both humans and animals to inform AMU/AMR research and policy. To provide highlights of CARSS data on antimicrobial use in humans and animals, AMR trends in human infections in both hospital and community settings and AMR bacteria found in food production animals. Information on AMU in animals and humans is purchased and additional information on AMU in animals is collected through the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS). AMR data in humans focuses on first priority organisms. Data on priority organisms for hospital-based AMR is collected through Canadian Nosocomial Infection Surveillance Program (CNISP), Canadian Tuberculosis Laboratory Surveillance System (CTBLSS), Canadian Tuberculosis Laboratory Surveillance System (CTBRS), Canadian Tuberculosis Reporting System (CTBRS) and CIPARS....Continue Reading

Citations

Feb 2, 2017·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·S HaM Gale-Rowe
Mar 7, 2021·Medical Sciences : Open Access Journal·Vanmathy KasimanickamRamanathan Kasimanickam
Nov 12, 2020·Journal of Global Antimicrobial Resistance·Ousmane Oumou DialloJean-Marc Rolain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
Denise GravelCanadian Nosocomial Infection Surveillance Program
Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
K AmaratungaAntimicrobial Resistance (AMR) Surveillance Task Group
The New Zealand Medical Journal
Deborah A Williamson, Helen Heffernan
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Andrew E SimorCommunity and Hospital Infection Control Association–Canada
© 2022 Meta ULC. All rights reserved